Kraig Biocraft Laboratories, Inc.
KBLB
$0.14
$0.001.05%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 47.83% | -107.91% | -21.02% | 29.55% | -96.61% |
| Total Depreciation and Amortization | 15.35% | -41.73% | 547.37% | -92.13% | 996.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -99.75% | 19,322.22% | 107.64% | -4,026.67% | 102.48% |
| Change in Net Operating Assets | 104.47% | -37.03% | 10.52% | -17.57% | 64.89% |
| Cash from Operations | 2.68% | -4.24% | -1.98% | 15.22% | -57.06% |
| Capital Expenditure | -- | 100.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -67.06% | 51.36% | -- | -- | -- |
| Cash from Investing | -67.77% | 55.26% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -50.00% | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -200.00% | 1,244.89% | -206.32% | -- | -- |
| Cash from Financing | -40.92% | 48.13% | 334.96% | -- | 100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -71.23% | 100.82% | 240.61% | 46.54% | -55.90% |